Evidence map›Paper›PMID 41563796›Full record

ArticleJournal of the American Society of Nephrology : JASN2026

The Role of Analysis Populations and Estimands in Clinical Trials.

Mariana Murea, Matthew P Goldman, Michael Allon, Haiying Chen

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mariana MureaDepartment of Internal Medicine, Section on Nephrology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Matthew P GoldmanDepartment of Vascular and Endovascular Surgery, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina.ORCID 0000-0001-6771-169
Michael AllonDivision of Nephrology, Department of Medicine, University of Alabama School of Medicine, Birmingham, Alabama.
Haiying ChenDivision of Public Health Sciences, Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina.ORCID 0000-0002-9712-5963

Funding

A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS TrialR01AG071803 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALLON, MICHAEL, MUREA, MARIANA · 2021 to 2025
$5.6M
A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney diseaseR03AG060178 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MUREA, MARIANA · 2018 to 2019
$233k
NIA NIH HHS R01 AG071803NIA NIH HHS R03 AG060178
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hemodialysisrandomized controlled trialsvascular access

Identifiers

PMID41563796
PMCPMC12889945

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.